Shuttle Pharmaceuticals Holdings (SHPH) Total Current Liabilities (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Total Current Liabilities history runs 6 years deep, the most recent figure standing at $8.3 million for Q1 2026.

• On a quarterly basis, Total Current Liabilities rose 366.04% year-over-year to $8.3 million in Q1 2026; TTM through Mar 2026 was $8.3 million, a 366.04% increase from a year earlier, with the FY2025 full-year figure at $8.0 million, up 419.43% from the prior year.
• Total Current Liabilities advanced to $8.3 million in Q1 2026 per SHPH's latest filing, from $8.0 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $8.3 million in Q1 2026 and bottomed at $493682.0 in Q2 2023.
• The 5-year median for Total Current Liabilities is $1.5 million (2024), against an average of $2.2 million.
• Across the five-year window, Total Current Liabilities tumbled 56.0% in 2022 and jumped 419.43% in 2025, its largest moves.
• Year by year, Total Current Liabilities stood at $975676.0 in 2022, then advanced by 6.82% to $1.0 million in 2023, then jumped by 47.16% to $1.5 million in 2024, then soared by 419.43% to $8.0 million in 2025, then climbed by 4.25% to $8.3 million in 2026.
• Per Business Quant, the three latest SHPH Total Current Liabilities figures stand at $8.3 million (Q1 2026), $8.0 million (Q4 2025), and $2.0 million (Q3 2025).